Burnham S, Iaccarino L, Pontecorvo M, Fleisher A, Lu M, Collins E
Brain Commun. 2024; 6(1):fcad305.
PMID: 38187878
PMC: 10768888.
DOI: 10.1093/braincomms/fcad305.
Mena A, Strafella A
Clin Park Relat Disord. 2022; 7:100155.
PMID: 35880206
PMC: 9307942.
DOI: 10.1016/j.prdoa.2022.100155.
Riley K, Graner B, Veronesi M
J Neuroimaging. 2022; 32(4):565-581.
PMID: 35470528
PMC: 9545715.
DOI: 10.1111/jon.13001.
Stamelou M, Respondek G, Giagkou N, Whitwell J, Kovacs G, Hoglinger G
Nat Rev Neurol. 2021; 17(10):601-620.
PMID: 34426686
DOI: 10.1038/s41582-021-00541-5.
Wolters E, Papma J, Verfaillie S, Visser D, Weltings E, Groot C
Neurology. 2021; 97(10):e1017-e1030.
PMID: 34210823
PMC: 8448551.
DOI: 10.1212/WNL.0000000000012448.
Neuroinflammation and Tau Colocalize in vivo in Progressive Supranuclear Palsy.
Malpetti M, Passamonti L, Rittman T, Jones P, Vazquez Rodriguez P, Bevan-Jones W
Ann Neurol. 2020; 88(6):1194-1204.
PMID: 32951237
PMC: 7116392.
DOI: 10.1002/ana.25911.
A multicentre longitudinal study of flortaucipir (18F) in normal ageing, mild cognitive impairment and Alzheimer's disease dementia.
Pontecorvo M, Devous M, Kennedy I, Navitsky M, Lu M, Galante N
Brain. 2019; 142(6):1723-1735.
PMID: 31009046
PMC: 6536847.
DOI: 10.1093/brain/awz090.
In vivo binding of a tau imaging probe, [ C]PBB3, in patients with progressive supranuclear palsy.
Endo H, Shimada H, Sahara N, Ono M, Koga S, Kitamura S
Mov Disord. 2019; 34(5):744-754.
PMID: 30892739
PMC: 6593859.
DOI: 10.1002/mds.27643.
Accumulation of Tau Protein, Metabolism and Perfusion-Application and Efficacy of Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT) Imaging in the Examination of Progressive Supranuclear Palsy (PSP) and....
Alster P, Madetko N, Koziorowski D, Krolicki L, Budrewicz S, Friedman A
Front Neurol. 2019; 10:101.
PMID: 30837933
PMC: 6383629.
DOI: 10.3389/fneur.2019.00101.
F-flortaucipir (AV-1451) tau PET in frontotemporal dementia syndromes.
Tsai R, Bejanin A, Lesman-Segev O, LaJoie R, Visani A, Bourakova V
Alzheimers Res Ther. 2019; 11(1):13.
PMID: 30704514
PMC: 6357510.
DOI: 10.1186/s13195-019-0470-7.
Imaging Markers of Progression in Parkinson's Disease.
Strafella A, Bohnen N, Pavese N, Vaillancourt D, van Eimeren T, Politis M
Mov Disord Clin Pract. 2019; 5(6):586-596.
PMID: 30637278
PMC: 6277366.
DOI: 10.1002/mdc3.12673.
Tau PET imaging in neurodegenerative tauopathies-still a challenge.
Leuzy A, Chiotis K, Lemoine L, Gillberg P, Almkvist O, Rodriguez-Vieitez E
Mol Psychiatry. 2019; 24(8):1112-1134.
PMID: 30635637
PMC: 6756230.
DOI: 10.1038/s41380-018-0342-8.
The Role of Tau Imaging in Parkinsonian Disorders.
Hammes J, Drzezga A, van Eimeren T
Curr Neurol Neurosci Rep. 2018; 18(12):86.
PMID: 30293094
DOI: 10.1007/s11910-018-0898-3.
The development and validation of tau PET tracers: current status and future directions.
Okamura N, Harada R, Ishiki A, Kikuchi A, Nakamura T, Kudo Y
Clin Transl Imaging. 2018; 6(4):305-316.
PMID: 30148121
PMC: 6096533.
DOI: 10.1007/s40336-018-0290-y.
[Tauopathies : From molecule to therapy].
Kovacs G, Respondek G, van Eimeren T, Holler E, Levin J, Muller U
Nervenarzt. 2018; 89(10):1083-1094.
PMID: 30120488
DOI: 10.1007/s00115-018-0584-3.
Tau Imaging in Parkinsonism: What Have We Learned So Far?.
Whitwell J
Mov Disord Clin Pract. 2018; 5(2):118-130.
PMID: 30035155
PMC: 6053061.
DOI: 10.1002/mdc3.12584.
Regional cortical perfusion on arterial spin labeling MRI in dementia with Lewy bodies: Associations with clinical severity, glucose metabolism and tau PET.
Nedelska Z, Senjem M, Przybelski S, Lesnick T, Lowe V, Boeve B
Neuroimage Clin. 2018; 19:939-947.
PMID: 30003031
PMC: 6039836.
DOI: 10.1016/j.nicl.2018.06.020.
Comparison of F-T807 and F-THK5117 PET in a Mouse Model of Tau Pathology.
Brendel M, Yousefi B, Blume T, Herz M, Focke C, Deussing M
Front Aging Neurosci. 2018; 10:174.
PMID: 29930508
PMC: 5999706.
DOI: 10.3389/fnagi.2018.00174.
[The importance of molecular imaging (PET) in the diagnostics of dementia].
Tscheuschler M, Gebest M, Jessen F, Drzezga A
Nervenarzt. 2018; 89(7):843-856.
PMID: 29916030
DOI: 10.1007/s00115-018-0533-1.
New Imaging Markers for Movement Disorders.
Ghadery C, Strafella A
Curr Neurol Neurosci Rep. 2018; 18(5):22.
PMID: 29616343
DOI: 10.1007/s11910-018-0830-x.
